AstraZeneca wins shareholder approval for New York listing ⊕⊕
found
a story from Financial Times ✅ › Financial Times
Move by FTSE’s biggest company gains support of 99% of shareholders who voted in blow to London market
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.